CORZ vs CLSK

For growth investors, CleanSpark, Inc.

(CLSK) is the stronger pick with 102. 2% revenue growth year-over-year, versus -37. 5% for Core Scientific, Inc. (CORZ). CleanSpark, Inc. (CLSK) offers the better valuation at 12. 9x trailing P/E, making it the more compelling value choice. Analysts rate Core Scientific, Inc. (CORZ) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Core Scientific, Inc.

(CORZ) delivered a total return of +616. 0%, compared to -19. 8% for CleanSpark, Inc. (CLSK). Over 10 years, the gap is even starker: CORZ returned +616. 0% versus CLSK's -83. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Core Scientific, Inc.

(CORZ) is the lower-risk stock at 2. 50β versus CleanSpark, Inc. 's 3. 39β — meaning CLSK is approximately 36% more volatile than CORZ relative to the S&P 500.

By revenue growth (latest reported year), CleanSpark, Inc.

(CLSK) is pulling ahead at 102. 2% versus -37. 5% for Core Scientific, Inc. (CORZ). On earnings-per-share growth, the picture is similar: CleanSpark, Inc. grew EPS 262. 3% year-over-year, compared to 82. 9% for Core Scientific, Inc.. Over a 3-year CAGR, CLSK leads at 79. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CleanSpark, Inc.

(CLSK) is the more profitable company, earning 47. 6% net margin versus -90. 5% for Core Scientific, Inc. — meaning it keeps 47. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLSK leads at 41. 6% versus -45. 4% for CORZ. At the gross margin level — before operating expenses — CLSK leads at 41. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for CLSK: 39.

4% to $20. 21.

In this comparison, CLSK (0.

2% yield) pays a dividend. CORZ does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Core Scientific, Inc.

(CORZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+616. 0% 10Y return). CleanSpark, Inc. (CLSK) carries a higher beta of 3. 39 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CORZ: +616. 0%, CLSK: -83. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CORZ is a small-cap quality compounder stock; CLSK is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.